Once-Weekly somapacitan vs daily GH in children with GH deficiency: Results from a randomized phase 2 trial

Rasmus Vestergaard Juul, REAL 3 study group

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Once-Weekly somapacitan vs daily GH in children with GH deficiency: Results from a randomized phase 2 trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science